Chen Dan et al. reported that obviously lower pre-treatment counts of CD3+, CD3+CD4+, and CD4+/CD8+ cells, as well as evidently elevated counts of CD3+ CD8+ cells in 69 ITP patients than those in 40 healthy controls [59]. The gene discussed is CD4; the disease is autoimmune thrombocytopenic purpura.